Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points.
Saved in:
| Title: | Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points. |
|---|---|
| Authors: | Fondevila MF; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain., Mercado-Gómez M; Liver Disease Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, and CIBER de Enfermedades Hepaticas y Digestivas (CIBERehd), Spain., Rodríguez A; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain., Gonzalez-Rellan MJ; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain., Iruzubieta P; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Research Institute Marqués de Valdecilla (IDIVAL), Santander, Spain., Valentí V; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain., Escalada J; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain., Schwaninger M; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany., Prevot V; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, European Genomic Institute for Diabetes (EGID), F-59000 Lille, France., Dieguez C; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain., Crespo J; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Research Institute Marqués de Valdecilla (IDIVAL), Santander, Spain., Frühbeck G; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain., Martinez-Chantar ML; Liver Disease Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, and CIBER de Enfermedades Hepaticas y Digestivas (CIBERehd), Spain. Electronic address: mlmartinez@cicbiogune.es., Nogueiras R; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Galician Agency of Innovation (GAIN), Santiago de Compostela, Spain. Electronic address: ruben.nogueiras@usc.es. |
| Source: | Journal of hepatology [J Hepatol] 2021 Feb; Vol. 74 (2), pp. 469-471. Date of Electronic Publication: 2020 Oct 20. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33096086 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fondevila+MF%22">Fondevila MF</searchLink>; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain.<br /><searchLink fieldCode="AU" term="%22Mercado-Gómez+M%22">Mercado-Gómez M</searchLink>; Liver Disease Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, and CIBER de Enfermedades Hepaticas y Digestivas (CIBERehd), Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez+A%22">Rodríguez A</searchLink>; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Rellan+MJ%22">Gonzalez-Rellan MJ</searchLink>; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain.<br /><searchLink fieldCode="AU" term="%22Iruzubieta+P%22">Iruzubieta P</searchLink>; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Research Institute Marqués de Valdecilla (IDIVAL), Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Valentí+V%22">Valentí V</searchLink>; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Escalada+J%22">Escalada J</searchLink>; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Schwaninger+M%22">Schwaninger M</searchLink>; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Prevot+V%22">Prevot V</searchLink>; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, European Genomic Institute for Diabetes (EGID), F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Dieguez+C%22">Dieguez C</searchLink>; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain.<br /><searchLink fieldCode="AU" term="%22Crespo+J%22">Crespo J</searchLink>; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Research Institute Marqués de Valdecilla (IDIVAL), Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Frühbeck+G%22">Frühbeck G</searchLink>; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Obesity Area, Clínica Universidad de Navarra and IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Chantar+ML%22">Martinez-Chantar ML</searchLink>; Liver Disease Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, and CIBER de Enfermedades Hepaticas y Digestivas (CIBERehd), Spain. Electronic address: mlmartinez@cicbiogune.es.<br /><searchLink fieldCode="AU" term="%22Nogueiras+R%22">Nogueiras R</searchLink>; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn), Spain; Galician Agency of Innovation (GAIN), Santiago de Compostela, Spain. Electronic address: ruben.nogueiras@usc.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228503886%22">Journal of hepatology</searchLink> [J Hepatol] 2021 Feb; Vol. 74 (2), pp. 469-471. <i>Date of Electronic Publication: </i>2020 Oct 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8503886 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0641 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201688278%22">01688278 </searchLink><i>NLM ISO Abbreviation: </i>J Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33096086 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jhep.2020.09.027 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 469 Titles: – TitleFull: Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fondevila MF – PersonEntity: Name: NameFull: Mercado-Gómez M – PersonEntity: Name: NameFull: Rodríguez A – PersonEntity: Name: NameFull: Gonzalez-Rellan MJ – PersonEntity: Name: NameFull: Iruzubieta P – PersonEntity: Name: NameFull: Valentí V – PersonEntity: Name: NameFull: Escalada J – PersonEntity: Name: NameFull: Schwaninger M – PersonEntity: Name: NameFull: Prevot V – PersonEntity: Name: NameFull: Dieguez C – PersonEntity: Name: NameFull: Crespo J – PersonEntity: Name: NameFull: Frühbeck G – PersonEntity: Name: NameFull: Martinez-Chantar ML – PersonEntity: Name: NameFull: Nogueiras R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2021 Feb Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1600-0641 Numbering: – Type: volume Value: 74 – Type: issue Value: 2 Titles: – TitleFull: Journal of hepatology Type: main |
| ResultId | 1 |